» Articles » PMID: 39091735

Bone Mineral Density Affects Tumor Growth by Shaping Microenvironmental Heterogeneity

Overview
Journal bioRxiv
Date 2024 Aug 2
PMID 39091735
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer bone metastasis is the leading cause of mortality in patients with advanced breast cancer. Although decreased mineral density is a known risk factor for bone metastasis, the underlying mechanisms remain poorly understood because studying the isolated effect of bone mineral density on tumor heterogeneity is challenging with conventional approaches. Here, we investigate how bone mineral content affects tumor growth and microenvironmental complexity by combining single-cell RNA-sequencing with mineral-containing or mineral-free decellularized bone matrices. We discover that the absence of bone mineral significantly influences fibroblast and immune cell heterogeneity, promoting phenotypes that increase tumor growth and alter the response to injury or disease. Importantly, we observe that the stromal response to matrix mineral content depends on host immunocompetence and the murine tumor model used. Collectively, our findings suggest that bone mineral density affects tumor growth by altering microenvironmental complexity in an organism-dependent manner.

References
1.
Gourgas O, Lemire G, Eaton A, Alshahrani S, Duker A, Li J . Specific heterozygous variants in MGP lead to endoplasmic reticulum stress and cause spondyloepiphyseal dysplasia. Nat Commun. 2023; 14(1):7054. PMC: 10624854. DOI: 10.1038/s41467-023-41651-6. View

2.
Zhang W, Xu Z, Hao X, He T, Li J, Shen Y . Bone Metastasis Initiation Is Coupled with Bone Remodeling through Osteogenic Differentiation of NG2+ Cells. Cancer Discov. 2022; 13(2):474-495. PMC: 9905315. DOI: 10.1158/2159-8290.CD-22-0220. View

3.
Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

4.
Williams C, Yeh E, Soloff A . Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy. NPJ Breast Cancer. 2016; 2. PMC: 4794275. DOI: 10.1038/npjbcancer.2015.25. View

5.
Kitajima I, Maruyama I, Matsubara H, Osame M, Igata A . Immune dysfunction in hypophosphatemic vitamin D-resistant rickets: immunoregulatory reaction of 1 alpha(OH) vitamin D3. Clin Immunol Immunopathol. 1989; 53(1):24-31. DOI: 10.1016/0090-1229(89)90097-4. View